Ilika’s Brompton development programme gives investors a more direct read on whether its solid-state battery technology can win real-world commercial use...
GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...
Lime remains a basic but important reagent in mineral processing because it affects pH control, mineral separation, froth behaviour and wider site management...
The UK IT services provider said it delivered strong second-half growth across its divisions, lifted Workday Products ARR above £89 million and expects FY26 revenue ahead of consensus with adjusted..
Plus500 reported record customer income of $270.6 million in the first quarter of 2026, supported by higher customer engagement, growth in non-OTC revenue and continued expansion in the US...
Kailera Therapeutics priced a $625 million Nasdaq IPO, marking the largest biotech listing by proceeds and delivering a significant valuation uplift for RTW Biotech Opportunities...
High-level data from the MIRANDA study showed AstraZeneca’s IL-33-targeting biologic tozorakimab significantly lowered annualised moderate-to-severe COPD exacerbations and was generally well tolerated...
The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by phase III DREAMM-7 data showing progression-free and overall survival benefits...
Atlas Metals has received net proceeds of approximately £1.63 million from its Second Loan and appointed RPG Crouch Chapman LLP as auditor for the year ending 31 December 2025...
Genflow Biosciences has entered a fully funded collaboration with Acuitas Therapeutics to apply lipid nanoparticle delivery technology to its SIRT6 mRNA platform, supporting preclinical development for age-related diseases...
Firering Strategic Minerals reports a two-year supply contract with a major copper producer, while its Limeco operation in Zambia reaches near-breakeven and advances capacity expansion plans...
Dr. Conrad Ivie breaks down why more physicians are burning out while owning less of the healthcare system they power. From building Tennessee’s largest orthopaedic group to launching Physicians Capital,..
Cash flow, not profit, is emerging as the defining challenge for SMEs. Ed Rimmer explains why businesses must rethink funding strategies as traditional lending falls short in volatile conditions...
Chesnara’s 2025 results showed higher operating capital generation, stronger cash generation and an improved balance sheet under its new reporting metrics. With acquisitions progressing and the dividend rising 6%, the..
Meren Energy reported strong full-year 2025 results, with production in line with guidance, $261.8 million in cash flow from operations, $288.6 million in free cash flow, and $420.0 million of..
Finseta said it will issue 799,087 retail offer shares at 8.5p, contributing to a £0.9 million fundraising alongside the placing and subscription. Admission of the new shares to AIM is..
The West Africa-focused gold company says the funding package, combined with its recent fundraise, is expected to fully finance Sanankoro to production and supports progress toward construction once permits are..
Ilika’s Brompton development programme gives investors a more direct read on whether its solid-state battery technology can win real-world commercial use...
GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...
Lime remains a basic but important reagent in mineral processing because it affects pH control, mineral separation, froth behaviour and wider site management...
The UK IT services provider said it delivered strong second-half growth across its divisions, lifted Workday Products ARR above £89 million and expects FY26 revenue ahead of consensus with adjusted PBT in line with market forecasts...
Plus500 reported record customer income of $270.6 million in the first quarter of 2026, supported by higher customer engagement, growth in non-OTC revenue and continued expansion in the US...
Kailera Therapeutics priced a $625 million Nasdaq IPO, marking the largest biotech listing by proceeds and delivering a significant valuation uplift for RTW Biotech Opportunities...
High-level data from the MIRANDA study showed AstraZeneca’s IL-33-targeting biologic tozorakimab significantly lowered annualised moderate-to-severe COPD exacerbations and was generally well tolerated...
The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by phase III DREAMM-7 data showing progression-free and overall survival benefits...
Atlas Metals has received net proceeds of approximately £1.63 million from its Second Loan and appointed RPG Crouch Chapman LLP as auditor for the year ending 31 December 2025...
Genflow Biosciences has entered a fully funded collaboration with Acuitas Therapeutics to apply lipid nanoparticle delivery technology to its SIRT6 mRNA platform, supporting preclinical development for age-related diseases...
Firering Strategic Minerals reports a two-year supply contract with a major copper producer, while its Limeco operation in Zambia reaches near-breakeven and advances capacity expansion plans...
Dr. Conrad Ivie breaks down why more physicians are burning out while owning less of the healthcare system they power. From building Tennessee’s largest orthopaedic group to launching Physicians Capital, he explains why real estate, financial fluency and long-term ownership are becoming essential for doctors who want more than income tied to time...
Cash flow, not profit, is emerging as the defining challenge for SMEs. Ed Rimmer explains why businesses must rethink funding strategies as traditional lending falls short in volatile conditions...
Chesnara’s 2025 results showed higher operating capital generation, stronger cash generation and an improved balance sheet under its new reporting metrics. With acquisitions progressing and the dividend rising 6%, the shares offer an 8.0% prospective yield that appears attractive relative to asset value...
Meren Energy reported strong full-year 2025 results, with production in line with guidance, $261.8 million in cash flow from operations, $288.6 million in free cash flow, and $420.0 million of RBL repayment...
Finseta said it will issue 799,087 retail offer shares at 8.5p, contributing to a £0.9 million fundraising alongside the placing and subscription. Admission of the new shares to AIM is expected on or around 20 April 2026...
The West Africa-focused gold company says the funding package, combined with its recent fundraise, is expected to fully finance Sanankoro to production and supports progress toward construction once permits are secured...
